n-acetylneuraminic acid has been researched along with 2019 Novel Coronavirus Disease in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 31 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Divya, VC; Saravanakarthikeyan, B | 1 |
| Chen, R; Huang, YW; Ji, CM; Liang, QZ; Liu, Y; Qin, P; Shi, FS; Wang, B; Yang, XL; Yang, YL | 1 |
| Ertelt, JM; Wu, ZL | 1 |
| Eessa, AM; Haroun, RA; Osman, WH | 1 |
| Ardá, A; Ereño-Orbea, J; Jiménez-Barbero, J; Lenza, MP; Moure, MJ; Oyenarte, I; Unione, L | 1 |
| Scheim, DE | 1 |
| Alu, A; Bi, Z; Chen, C; Chen, L; Chen, S; Cheng, W; Dai, L; Dong, H; Fan, C; Geng, J; Gou, M; He, C; He, X; He, Z; Hong, W; Huang, C; Huang, Q; Jia, G; Jiang, X; Kuang, D; Lei, H; Li, J; Li, X; Lu, G; Lu, S; Lu, T; Luo, M; Peng, X; Peng, Y; Qian, Z; Que, H; Ren, W; Shen, G; Song, X; Su, Z; Sun, Q; Tong, A; Wang, H; Wang, J; Wang, W; Wang, Z; Wei, X; Wei, Y; Yang, J; Yang, L; Yang, M; Yang, Y; Yu, W; Zhang, Z; Zhao, Y; Zhao, Z; Zhong, K; Zhou, Y; Zou, J | 1 |
| Hu, D; Li, C; Wang, DW; Wei, H; Wu, J; Zhao, M; Zheng, L | 1 |
| Law, B; Tremoleda, JL | 1 |
| Büll, C; Clausen, H; de Haan, CAM; de Vries, E; Huang, LZX; Liu, M; Narimatsu, Y; Smits, AA; van Kuppeveld, FJM | 1 |
| Bäckström, M; Liljeqvist, JÅ; Mirgorodskaya, E; Nordén, R; Nyström, K; Samuelsson, E | 1 |
| Cerbón, M; Cervantes-Torres, JB; Papy-Garcia, D; Ramos-Martínez, E; Ramos-Martínez, IE; Saavedra-Montañez, M; Sánchez-Betancourt, JI; Segura-Velázquez, RÁ; Zenteno, E | 1 |
| Brown, A; Moiseiwitsch, N; Sniecinski, R; Szlam, F; Zwennes, N | 1 |
| Fu, Y; Jiang, S; Li, P; Li, W; Liu, Z; Lu, L; Tang, J; Wang, C; Wang, Q; Xu, W | 1 |
| Tian, Z; Yang, H | 1 |
| Bieberich, E | 1 |
| Andrews, JR; Badiane, AS; Baum-Jones, E; Bei, AK; Ben-Mamoun, C; Boum, Y; Campbell, M; Cappello, M; Casanovas-Massana, A; Cherepanov, P; Costa, F; Dabiré, RK; Dai, Y; Deme, AB; Diagne, CT; Diagne, MM; Diallo, F; Diedhiou, Y; Dieye, B; Diouf, B; Faye, O; Faye, R; Filler, RB; Hodson, DZ; Huck, JD; Iwasaki, A; Kamath, K; Katz, BZ; Klein, J; Ko, AI; Lapidus, S; Liu, F; Lucas, C; Mangou, K; Mbarga, Y; Mbaye, AM; Mbengue, A; McClure, M; Moore, AJ; Moukoko, CEE; Muenker, MC; Ndiaye, D; Ndiaye, IM; Nery, N; Ouédraogo, JB; Parikh, S; Pouye, MN; Reis, MG; Ring, AM; Sadio, BD; Sall, AA; Sene, SD; Shon, J; Somé, FA; Srivathsan, A; Strine, MS; Sy, M; Tedder, R; Vélez, JCQ; Vigan-Womas, I; Wilen, CB; Wilson, M; Wisnewski, A | 1 |
| An, JE; Bae, PK; Kim, KH; Kim, L; Kwon, OS; Nazir, S; Seo, SE | 1 |
| Boons, GJ; Bouwman, KM; Caniels, TG; de Vries, RP; Fok, JA; Heesters, BA; Jiménez-Barbero, J; Kilavuzoglu, SE; Kimpel, ALM; Klassen, JS; Li, Z; Linthorst, MW; Liu, L; Nguyen, L; Pieters, RJ; Ríos Carrasco, M; Sanders, RW; Tomris, I; Unione, L; van der Woude, R; Verpalen, ECJM; Zaree, P | 1 |
| Chaudhary, M; Gupta, D; Harshan, KH; Negi, G; Parveen, N; Sharma, A | 1 |
| Das, T; Mukhopadhyay, C | 1 |
| Chu, X; Fan, Z; Liu, R; Tretyakova, E; Wang, M; Xiao, S; Yi, Y; Zhang, J; Zhang, L; Zhang, Y; Zhou, D; Zhu, X | 1 |
| Chen, J; Li, Y; Liu, C; Liu, X; Shi, L; Sun, A; Sun, H; Wang, X; Wang, Y; Yan, H; Yang, Z; Zhang, C | 1 |
| Engin, A; Engin, AB; Engin, ED | 1 |
| Robson, B | 1 |
| Car, H; Godlewska, K; Rogowski, K; Wielgat, P | 1 |
| Asuthkar, S; Caniglia, JL; Guda, MR; Tsung, AJ; Velpula, KK | 1 |
| Buonomo, AR; Capoluongo, E; Castaldo, G; Di Domenico, C; Gentile, I; Nardelli, C; Pinchera, B; Scaglione, GL; Scotto, R; Setaro, M; Zappulo, E | 1 |
| Capasso, D; Delre, P; Di Gaetano, S; Mangiatordi, GF; Pedone, E; Pirone, L; Saviano, M | 1 |
| Baker, K; Bowen, T; Byrd-Leotis, L; Cummings, RD; Lasanajak, Y; Song, X; Steinhauer, DA; Suthar, MS | 1 |
| Chen, M; Deng, Y; Hu, M; Lai, X; Li, C; Liu, X; Song, Y; Wang, S | 1 |
5 review(s) available for n-acetylneuraminic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody.
Topics: Basigin; Binding Sites; COVID-19; Erythrocytes; Glycosylation; Hemagglutination; Hemagglutinins, Viral; Humans; N-Acetylneuraminic Acid; Polysaccharides; Protein Binding; SARS-CoV-2; Sialoglycoproteins; Spike Glycoprotein, Coronavirus; Viral Fusion Proteins; Virus Internalization | 2022 |
Heparan Sulfate and Sialic Acid in Viral Attachment: Two Sides of the Same Coin?
Topics: COVID-19; Glycoconjugates; Heparitin Sulfate; Humans; N-Acetylneuraminic Acid; Receptors, Virus; SARS-CoV-2; Sialic Acids; Sulfates; Virus Attachment; Viruses | 2022 |
Synthesis, Processing, and Function of N-Glycans in N-Glycoproteins.
Topics: Acetylglucosamine; Asparagine; COVID-19; Fucose; Galactose; Glycoproteins; Humans; Lipids; N-Acetylneuraminic Acid; Polysaccharides | 2023 |
Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.
Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Gastrointestinal Diseases; Humans; N-Acetylneuraminic Acid; Pandemics; Pneumonia, Viral; SARS-CoV-2; Virus Attachment | 2020 |
Immunopathology of galectin-3: an increasingly promising target in COVID-19.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Galectin 3; Humans; N-Acetylneuraminic Acid; Pandemics; Pneumonia, Viral; SARS-CoV-2 | 2020 |
26 other study(ies) available for n-acetylneuraminic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
In silico exploration of enzymes involved in sialic acid biosynthesis and their possible role in SARS-CoV-2 infection.
Topics: COVID-19; Humans; N-Acetylneuraminic Acid; SARS-CoV-2; Sialic Acids; Spike Glycoprotein, Coronavirus; Virus Attachment | 2021 |
Roles of Two Major Domains of the Porcine Deltacoronavirus S1 Subunit in Receptor Binding and Neutralization.
Topics: Animals; Cats; CD13 Antigens; Chlorocebus aethiops; COVID-19; Cricetinae; Deltacoronavirus; Erythrocytes; Glycosylation; HEK293 Cells; Humans; Intestine, Small; Mice; Mutation; N-Acetylneuraminic Acid; NIH 3T3 Cells; Protein Binding; Protein Domains; Risk; SARS-CoV-2; Swine; Swine Diseases; Vero Cells; Viral Proteins | 2021 |
Fluorescent glycan fingerprinting of SARS2 spike proteins.
Topics: Carbocyanines; COVID-19; Electrophoresis, Polyacrylamide Gel; Fluorescent Dyes; Fucose; Glycosylation; Humans; N-Acetylneuraminic Acid; Optical Imaging; Polysaccharides; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
Evaluation of serum total sialic acid in moderate COVID-19 patients with and without gastrointestinal tract manifestations.
Topics: Adult; Biomarkers; COVID-19; Enzyme-Linked Immunosorbent Assay; Female; Gastrointestinal Tract; Humans; Male; Middle Aged; Mucus; N-Acetylneuraminic Acid; SARS-CoV-2 | 2022 |
The SARS-CoV-2 Spike Glycoprotein Directly Binds Exogeneous Sialic Acids: A NMR View.
Topics: Binding Sites; COVID-19; Galactose; Humans; N-Acetylneuraminic Acid; SARS-CoV-2; Sialic Acids; Spike Glycoprotein, Coronavirus; Trisaccharides | 2022 |
Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells.
Topics: Animals; COVID-19; Histones; Mice; N-Acetylneuraminic Acid; Protein Subunits; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Virus Internalization | 2022 |
Neuraminidase inhibitor treatment is associated with decreased mortality in COVID-19 patients: a retrospective analysis.
Topics: Antiviral Agents; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Humans; N-Acetylneuraminic Acid; Neuraminidase; Retrospective Studies | 2022 |
Success for our first Virtual LASA Annual Conference.
Topics: COVID-19; Humans; Lipids; N-Acetylneuraminic Acid; Pseudomonas aeruginosa | 2022 |
Human-type sialic acid receptors contribute to avian influenza A virus binding and entry by hetero-multivalent interactions.
Topics: Animals; COVID-19; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza Pandemic, 1918-1919; Influenza, Human; N-Acetylneuraminic Acid; Receptors, Cell Surface; Receptors, Virus | 2022 |
Sialic Acid and Fucose Residues on the SARS-CoV-2 Receptor-Binding Domain Modulate IgG Antibody Reactivity.
Topics: Animals; Antibodies, Viral; CHO Cells; COVID-19; Cricetinae; Cricetulus; Fucose; Humans; Immunoglobulin G; N-Acetylneuraminic Acid; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid.
Topics: COVID-19; Fibrin; Fibrinogen; Fibrinolysis; Hemostatics; Humans; N-Acetylneuraminic Acid; Neuraminidase; Polymerization; SARS-CoV-2; Thrombosis | 2022 |
Chemically Modified Bovine β-Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks.
Topics: Animals; Antibodies, Viral; Cattle; COVID-19; Disease Outbreaks; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins; HIV Fusion Inhibitors; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H7N9 Subtype; Influenza Vaccines; Influenza, Human; Lactoglobulins; Mice; N-Acetylneuraminic Acid; Orthomyxoviridae Infections; SARS-CoV-2 | 2022 |
Sialic acid linkage-specific quantitative N-glycoproteomics using selective alkylamidation and multiplex TMT-labeling.
Topics: Acetylglucosamine; COVID-19; Glycopeptides; Glycoproteins; Glycosyltransferases; Humans; N-Acetylneuraminic Acid; Polysaccharides; Sialic Acids; Tandem Mass Spectrometry | 2022 |
Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein.
Topics: Antibodies, Viral; COVID-19; Cross Reactions; Epitopes; Humans; Malaria; N-Acetylneuraminic Acid; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2022 |
Discrimination of the H1N1 and H5N2 Variants of Influenza A Virus Using an Isomeric Sialic Acid-Conjugated Graphene Field-Effect Transistor.
Topics: COVID-19; Graphite; Hemagglutinin Glycoproteins, Influenza Virus; Hemagglutinins; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N2 Subtype; Influenza, Human; N-Acetylneuraminic Acid; Receptors, Virus; SARS-CoV-2 | 2023 |
SARS-CoV-2 Spike N-Terminal Domain Engages 9-
Topics: COVID-19; Humans; N-Acetylneuraminic Acid; SARS-CoV-2; Sialic Acids; Spike Glycoprotein, Coronavirus | 2023 |
SARS-CoV-2 Binding to Terminal Sialic Acid of Gangliosides Embedded in Lipid Membranes.
Topics: COVID-19; G(M1) Ganglioside; Gangliosides; Humans; N-Acetylneuraminic Acid; SARS-CoV-2 | 2023 |
Comparison and Possible Binding Orientations of SARS-CoV-2 Spike N-Terminal Domain for Gangliosides GM3 and GM1.
Topics: COVID-19; G(M1) Ganglioside; G(M3) Ganglioside; Gangliosides; Humans; N-Acetylneuraminic Acid; SARS-CoV-2 | 2023 |
Novel mono- and multivalent N-acetylneuraminic acid glycoclusters as potential broad-spectrum entry inhibitors for influenza and coronavirus infection.
Topics: Animals; Antiviral Agents; Chickens; COVID-19; Cyclodextrins; HIV Fusion Inhibitors; Humans; Influenza, Human; N-Acetylneuraminic Acid | 2023 |
Effects of the glycosylation of the receptor binding domain (RBD dimer)-based Covid-19 vaccine (ZF2001) on its humoral immunogenicity and immunoreactivity.
Topics: Angiotensin-Converting Enzyme 2; Antibodies, Neutralizing; Antibodies, Viral; COVID-19; COVID-19 Vaccines; Glycosylation; Humans; N-Acetylneuraminic Acid; Polysaccharides; SARS-CoV-2; Viral Vaccines | 2023 |
Bioinformatics studies on a function of the SARS-CoV-2 spike glycoprotein as the binding of host sialic acid glycans.
Topics: Algorithms; Amino Acid Motifs; Betacoronavirus; Binding Sites; Computational Biology; Coronavirus Infections; COVID-19; Humans; Molecular Conformation; N-Acetylneuraminic Acid; Pandemics; Pneumonia, Viral; Polysaccharides; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Tryptophan | 2020 |
Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Humans; Mice; Middle East Respiratory Syndrome Coronavirus; N-Acetylneuraminic Acid; Pandemics; Pneumonia, Viral; Receptors, Pattern Recognition; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Sialic Acid Binding Immunoglobulin-like Lectins; Toll-Like Receptors; Virus Internalization | 2020 |
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
Topics: Adult; Aged; Aged, 80 and over; COVID-19; Female; Fusobacterium; Fusobacterium Infections; Humans; Male; Microbiota; Middle Aged; Mouth; N-Acetylneuraminic Acid; Nasopharynx; Pandemics; SARS-CoV-2 | 2021 |
More Is Always Better Than One: The N-Terminal Domain of the Spike Protein as Another Emerging Target for Hampering the SARS-CoV-2 Attachment to Host Cells.
Topics: Binding Sites; COVID-19; Drug Repositioning; Humans; Molecular Dynamics Simulation; N-Acetylneuraminic Acid; Protein Binding; Protein Domains; SARS-CoV-2; Small Molecule Libraries; Spike Glycoprotein, Coronavirus; Virus Attachment | 2021 |
SARS-CoV-2 and other coronaviruses bind to phosphorylated glycans from the human lung.
Topics: Animals; Cattle; COVID-19; Host Microbial Interactions; Humans; Lung; Mannose; Middle East Respiratory Syndrome Coronavirus; N-Acetylneuraminic Acid; Phosphorylation; Polysaccharides; Protein Array Analysis; Protein Binding; SARS-CoV-2; Spike Glycoprotein, Coronavirus | 2021 |
Sialic acid-conjugate modified doxorubicin nanoplatform for treating neutrophil-related inflammation.
Topics: Animals; COVID-19; Doxorubicin; Humans; Inflammation; Mice; N-Acetylneuraminic Acid; Neutrophils; SARS-CoV-2 | 2021 |